Loxapine succinate

Cat. No.: PI27833643

Description: Loxapine succinate belongs to the group of dibenzoxazepin derivatives. The active ingredient can suppress the effects of dopamine and serotonin. It is used for the treatment of mild to pathological restlessness in patients with schizophrenia or bipolar disorders.

Product Details

CAS	27833-64-3
Molecular Formula	C18H18ClN3O·C4H6O4
Molecular Weight	445.90
Product Status	Commercial
Uses	Psycholeptics
Molecular Size	Small
Controlled Substance	No

* Our products are for research use only.

Get in Touch

We’re glad to help you with your products and services demands. For any inquiry, question or recommendation, please send an email to or fill out the following form.

Name *

Phone

Email *

Address *

Products & Service of Interest *

Project Description

Verification Code *